Description
Manufacturer:
Sun Pharmaceutical Industries Ltd
Salt Composition:
Ursodeoxycholic acid (UDCA)
Description:
Ursocol SR 450mg Tab contains ursodeoxycholic acid (UDCA) in a sustained-release (SR) formulation, with a strength of 450mg per tablet. Similar to the immediate-release formulation, UDCA works by altering the composition of bile, reducing cholesterol saturation, and promoting the dissolution of cholesterol gallstones. It is also used in the management of primary biliary cirrhosis (PBC).
The sustained-release formulation is designed to release the medication slowly over time, which may allow for less frequent dosing, often once daily.
The dosage and duration of treatment depend on the specific condition and the patient’s characteristics, as determined by a healthcare professional specializing in liver or gastrointestinal disorders. Common side effects are generally mild and can include diarrhea. As with the immediate-release formulation, monitoring of liver function tests may be necessary during treatment.
Reviews
There are no reviews yet.